Candel Therapeutics (CADL) EBITDA Margin (2020 - 2022)
Candel Therapeutics (CADL) reported EBITDA Margin of 26132.26% for Q4 2022, up 10286774.0% on a YoY basis from N/an in Q4 2021, and up 8.78% sequentially from 28648.39% in Q3 2022.
Candel Therapeutics (CADL) EBITDA Margin (2020 - 2022) Analysis & Trends
Candel Therapeutics (CADL) has 3 years of EBITDA Margin data on file, last reported at 26132.26% in Q4 2022.
- For the quarter ending Q4 2022, EBITDA Margin rose 10286774.0% year-over-year to 26132.26%; the trailing twelve-month figure through Dec 2022 stood at 28000.81% (down 201394.0% YoY), and the FY2022 full-year result was 27777.6%, down 205160.0% from the prior year.
- EBITDA Margin climbed to 26132.26% in Q4 2022, from 28648.39% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 8448.39% in Q2 2020 to a low of 129000.0% in Q4 2021.
- A 3-year average of 30554.55% and a median of 25900.0% in 2021 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin tumbled 10924194 bps in 2021 and jumped 10286774 bps in 2022, its largest moves.
- Tracing CADL's EBITDA Margin over 3 years: stood at 19758.06% in 2020, then slumped by 553 bps to 129000.0% in 2021, then soared by 80 bps to 26132.26% in 2022.
- Business Quant data shows CADL's EBITDA Margin at 26132.26% in Q4 2022, 28648.39% in Q3 2022, and 28235.48% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -26,132.26% |
| Sep 30, 2022 | -28,648.39% |
| Jun 30, 2022 | -28,235.48% |
| Mar 31, 2022 | -28,987.10% |
| Dec 31, 2021 | -129,000.00% |
| Sep 30, 2021 | -25,900.00% |
| Jun 30, 2021 | -17,100.00% |
| Mar 31, 2021 | -15,022.58% |
| Dec 31, 2020 | -19,758.06% |
| Sep 30, 2020 | -8,867.74% |
| Jun 30, 2020 | -8,448.39% |